Date post: | 26-May-2015 |
Category: |
Education |
Upload: | tarun-yadav |
View: | 2,657 times |
Download: | 6 times |
Dr. Tarun Yadav
Department of Anesthesiology – JNMC, Sawangi(M) Wardha
1
1. Introduction2. Pathway O2-Brain 3.MAC (Definition and Values and factors effecting MAC)
4. Factors determining how quickly the inhalational agent reaches the alveoli reaches and the brain from the alveoli
5. Nitrous Oxide (N2O)5.1. physical properties, Pharmacology and side
effects)5.2. What is diffusion hypoxia? 5.3. Second gas effect
2
6. Halothane6.1. properties6.2. Metabolism6.3. Dosage, Administration an Supply6.4. Indications and contraindications6.5. Effect on Organ Systems6.6. Advantages and Disadvantages
3
7. Isoflurane and Sevoflurane7.1. properties7.2.Effect on Organ Systems7.3. Advantages and Disadvantages 7.4. Indications and contraindications
4
IV anesthesia : induce anesthesia Inhalation anesthesia : maintain anesthesia
IV anesthesia : mg/KG or microgram/Kg Inhalation anesthesia : Percentage of the volume
%EXAMPLE: 2 L/min. O2 + 4 L/min N2O
Conc. Of N2O = 4/(2+4) = 66%
5
INHALATIONAL ANAESTHETIC AGENTIntroduction
6
MAC Definition Minimal alveolar concentration (MAC): Is defined as the conc. At 1 atmosphere of
anesthetic in the alveoli that s required to produce immobility in 50% of adults patient subjected to a surgical incision
MAC is important to compare the potencies of various inhalational anesthetic agents
1.2 -1.3 MAC prevent movement in 95% of patients
7
MAC Value N2O = 105% Halothane = 0.75% Isoflurane = 1.16% Euflurane = 1.68% Sevoflurane = 2% Deslurane = 6%
N2O alone is unable to produce adequate anesthesia ( require high conc. )
8
9
No Effect on MAC Gender Duration of anesthesia Carbon dioxide tension (21-95 mmHg) Metabolic Acid base status Hypertension Hyperkalemia
10
Factors determining how quickly the inhalational agent reaches the alveoli?
1-Increasing the delivered concentrations of anesthetic
2- The gas flow rate through the anesthetic machine
3-Increasing minute ventilation MV = Respiratory Rate × Tidal volume
11
Factors determining how quickly the inhalational agent reaches the brain from the alveoli in order to establish anesthesia?
1- The rate of blood flow to the brain2- The solubility of the inhalational agent in
the brain3- The difference in the arterial and venous
concentration of the inhalational agent
12
NHALATIONAL ANAESTHETIC AGENT
Nitrous Oxide (N2O)
13
Physical property:- laughing- Not flammable- Odorless- Colorless- Tasteless
14
PHARMACOLOGY:- Good Analgesic- Weak anesthetic- Excreted via lungs- MAC = 105%- Lower water solubility- Not Metabolized in the body
15
SIDE EFFECTS:- Diffusion Hypoxia.- Effects on closed gas spaces.(nitrous oxide can
diffuse 20 times faster into closed spaces than it can be removed, resulting in expansion of pneumothorax, bowel gas, or air embolism or in an increase in pressure within noncompliant cavities such as the cranium or middle ear.
- CVS depression- Toxicity- Teratogenic
16
What is diffusion hypoxia? Diffusion hypoxia is a decrease in PO2 usually
observed as the patient is emerging from an inhalational anesthetic where nitrous oxide (N2O) was a component. The rapid outpouring of insoluble N2O can displace alveolar oxygen, resulting in hypoxia. All patients should receive supplemental O2 at the end of an anesthetic and during the immediate recovery period.
17
Second gas effect: The ability of the large volume uptake of one gas (first gas) to accelerate the rate of rise of the alveolar partial pressure of a concurrently administered companion gas (second gas) is known as the second gas effect.
Apr 12, 2023
Dr. M
ed. Khaled R
adaideh
18
Halothane
19
Synthesized in 1951.* Volatile liquid easily vaporized, stable, and nonflammable* Most potent inhalational anesthetic•MAC of 0.75%•Colorless liquid , pleasant smell , decomposed by light. So should be stored in container away from light and heat • It has low blood/gas solubility coeffient of 2.5 and thus induction of anasthesia is relatively rapid.
20
20% metabolized in liver by oxidative
pathways.
Major metabolites : bromin, chlorine,
Trifloroacetic acid, Trifloroacetylethanl
amide.
21
The induction dose varies from patient to patient. The maintenance dose varies from 0.5 to 1.5%.
Halothane may be administered with either oxygen or a mixture of oxygen and nitrous oxide.
How is Halothane Supplied Halothane is supplied in amber colored 250 mL
glass bottles, stabilized with thymol 0.01% (w/w). Store in cool, dry place and protect from undue
exposure to light.
22
Indications Halothane is indicated for the induction and
maintenance of general anesthesia. Contraindications Halothane is not recommended for obstetrical
anesthesia except when uterine relaxation is required.
23
Respiratory system: Halothane anesthesia progressively depresses
respiration. Its cause inhibition of salivary & bronchial secretion. Its may cause tachypnea & reduce in tidal volume and
alveolar ventilation . Its cause decrease in mucocillary function which lead
to sputum retention. It causes bronchodilation. Hypoxia, acidosis, or apnea
may develop during deep anesthesia.
24
Cardiovascular system: Halothane anesthesia reduces the blood pressure, and cause
bradycardia.(atropin may reverse bradycardia.). It cause myocardial relaxation & Hypotention. Its also causes dilation of the vessels of the skin and skeletal
muscles Halothane maybe advantages In pts with CAD , bcz of
decrease of oxygen demand. Arrhythemias are very commone .(especially with
epinephrine).◦ To minimize effects :
Avoid hypoxemia and hypercapnia Avoid conc. Of adrenaline higher than 1 in 10000
25
Gastro intestinal tract:Inhibition of gastrointestinal motility.
Cause sever post. Operative nausea & vomiting Uterus: Halothane relaxes uterine muscle, may cause postpartum
hemorrhage . Concentration of less than 0.5 % associated with increase
blood loss during therapeutic abortion.Skeletal muscle: Its cause skeletal muscle relaxation . Postoperatively , shivering is common , this increase oxygen
requirement>>> which cause hypoxemia
26
Hepatic dysfunction: Two type of dysfunction: 1- Type I hepatotoxicity ,mild, associated with derangement
in liver function test , this result from metabolic of Halothane in liver. results from reductive (anaerobic) biotransformation of halothane rather than the normal oxidative pathway.
2- Type II hepatotoxicity: fulminate (uncommon); sever jaundice ,fever,progressing to fulminating hepatic necrosis,
Its increased by repeated exposure of the drugs.high mortality 30-70%
27
1- A careful anasthetic history .2- repeated exposure of halothane within
3 months should be avoided.3- History of unexplained jaundice or
pyrexia after previous exposure of halothane.
28
Rapid smooth induction . Minimal stimulation of salivary & bronchial
secretion. Brochiodilatation. Muscle relaxant . Relatively rapid recovery.
29
Poor analgesia.
Arrhythmias.
Post operatively shivering.
Possibility of liver toxicity.
30
Enflurane
MAC =1.68%
Potent cardiovascular depressant
Apr 12, 2023Dr. Med. Khaled Radaideh 31
IsofluraneProperties
- isomer of enflurane.- Carcinogenic (not approved)- colorless, volatile, liquid, pungent odor.- stable.- No preservative .- Non-flammable.
32
IsofluraneProperties
- Least soluble of the modern inhalational agent
equilibrate more rapidly
- Induction rapid theoretically (pungency??)
- pungency cough, breath holding.
33
Isofluraneeffects on systems:-
Respiratory:dose dependent depression of vetilation.CVS:- myocardial depressant (vitro Vs Clinical), coronary vasodilatation (coronary steal syndrome).uterus: relaxation of uterine muscles (same).
34
Isofluraneeffects on systems:-
CNS:
low concentration Vs High concentration.
Low : no change on the flow.
High : increase blood flow by
vasodilatation of the cerebral arteries.
-Muscles: relaxation (dose-dependent).
35
IsofluraneAdvantages and Disadvantages
Advantages-Rapid induction and recovery.-Little risk of hepatic or renal toxicity.-Cardiovascular stability. -Muscle relaxation.Disadvantages-Pungent odor.-Coronary vasodilatation.
36
SevofluraneProperties
-New drug.-Non flammable.-Pleasant smell.-MAC 2%.-Stable.-Low blood/gas partition coefficient faster equilibrium.- non irritant so the fastest for induction.
37
SevofluraneAdvantages and Disadvantages
Advantages 1 .Well tolerated (non-irritant, sweet odor), even at high
concentrations, making this the agent of choice for inhalational induction .
2 .Rapid induction and recovery (low blood:gas coefficient)
3 .Does not sensitize the myocardium to catecholamines as much as halothane.
4 .Does not result in carbon monoxide production with dry soda lime .
38
SevofluraneAdvantages and Disadvantages
Disadvantages 1 .Less potent than similar halogenated agents.
2 .Interacts with CO2 absorbers. In the presence of soda lime (and more with barium lime) compound A (a vinyl ether) is produced which is toxic to the brain, liver, and kidneys .
3 .About 5% is metabolized and elevation of serum fluoride levels has led to concerns about the risk of renal toxicity .
4 .Postoperative agitation may be more common in children then seen with halothane .
39
Sevofluraneeffects on systems
- - Respiratory:-non-irritant, depression.-CVS: same as isoflurane (slightly lower effect)-CNS: same as halothane and isoflurane.-Muscle relaxation: same as isoflurane.
40
Desflurane
MAC =6 %
41
42